Optimization of native E. coli-asparaginase therapy in standard risk-group children with acute lymphoblastic leukemia treated by the ALL-MB 2002 protocol M. Yu. Goroshkova , Yu. V. Rumyantseva , O. V. Aleinikova , S. A. Dudkin , L. G. Fechina , A. V. Shamardina , O. V. Streneva , K. L. Kondratchik , L. M. Minkina , E. S. Lapotentova , E. V. Inyushkina , O. B. Kozlova , E. V. Zhukovskaya , O. P. Khlebnikova , E. V. Basharova , V. N. Timofeeva , G. P. Pavlova , V. D. Zlobina , O. A. Utrobina , E. S. Banshchikova , K. S. Aslanyan , E. V. Kondakova , E. V. Tselousova , N. V. Myakova , T. V. Turobova , O. V. Ryskal , O. Yu. Fuks , V. V. Lebedev , N. F. Chipsanova , S. R. Varfolomeeva , A. I. Karachunsky Онкогематология（2022）
关键词
acute lymphoblastic leukemia, children, l-asparaginase, efficacy, toxicity
AI 理解论文
溯源树
样例
